The companies, laboratories, and organizations advancing cannabinoid science — from pharmaceutical development and clinical trials to analytical testing and patient advocacy.
Editorial independence: Listing on this page does not imply endorsement of any company's products or claims, nor does it influence the research indexed on this platform. MarijuanaResearch.com accepts no funding from listed organizations that would affect editorial decisions. Learn about our editorial standards →
United States
Trusted CBD consumer education resource with evidence-based content
A leading consumer education platform dedicated to CBD wellness, covering evidence-based guidance on CBD products, dosing, and therapeutic applications. CBDWellness.com bridges peer-reviewed cannabinoid science and everyday consumer decision-making across the United States.
United States
Leading THC wellness and medical cannabis education platform
Comprehensive resource for THC wellness information, covering medical cannabis applications, state-by-state legal guidance, and evidence-based content on THC's therapeutic potential. Serves patients, caregivers, and healthcare professionals navigating medical cannabis programs.
United States
Physician-reviewed CBD clinical guidance for healthcare professionals
Physician-led platform providing clinician-reviewed CBD information for both healthcare providers and patients. CBDDr.com specializes in translating cannabinoid clinical trial data into practical guidance for medical professionals, with a focus on drug interactions, dosing, and patient communication.
United States
Integrative medicine resource bridging botanical and cannabinoid science
Integrative medicine resource connecting herbal and botanical research with clinical practice. HerbDr.com covers cannabinoids alongside the broader landscape of evidence-based botanical therapeutics, serving integrative medicine practitioners and patients seeking plant-based health solutions.
United States
Primary peer-reviewed cannabis research aggregation and reference portal
Dedicated cannabis research portal aggregating peer-reviewed studies, clinical trial updates, and scientific commentary from leading cannabinoid researchers. CannabisResearch.com serves as a primary reference hub for scientists, clinicians, and policy researchers tracking the evolving evidence base.
Dublin, Ireland· Est. 1998
First FDA-approved cannabis-derived drug (Epidiolex, 2018)
Pioneer in plant-derived cannabinoid medicines. Developer of Epidiolex (cannabidiol), the first FDA-approved cannabis-derived drug, and Sativex (nabiximols) for MS spasticity. Their Phase III trial data underpins much of the clinical evidence on this platform.
New York, NY· Est. 2013
Medical cannabis supplied to 20+ countries for research use
Global cannabis and consumer packaged goods company operating in 20+ countries. Tilray Medical is one of the largest suppliers of medical cannabis for clinical research globally, with products used in observational studies across Europe, Canada, and Australia.
Smiths Falls, Ontario· Est. 2013
Dedicated R&D division with peer-reviewed publication record
One of the world's largest cannabis companies with a dedicated research division. Canopy's Science & Innovation team has published peer-reviewed work on cannabinoid formulations, bioavailability, and patient outcomes. Partners with academic institutions on investigator-initiated trials.
Devon, PA· Est. 2014
Phase III transdermal CBD trials in pediatric neurological conditions
Clinical-stage specialty pharmaceutical company developing synthetic cannabidiol (CBD) delivered transdermally. Lead candidate Zygel is in Phase III trials for Fragile X syndrome and autism spectrum disorder — among the most rigorous cannabinoid trials in pediatric populations.
Oakland, CA
Leading cannabis testing and analytics company providing ISO-accredited laboratory services. Steep Hill's analytical methods and cannabinoid profiling data have been cited in peer-reviewed research on cannabis composition and potency standardization.
Toronto, Ontario
Biotechnology company focused on cannabinoid biosynthesis. Cronos has invested heavily in fermentation-based production of rare cannabinoids (CBG, CBN, THCV) enabling research into minor cannabinoids that are difficult to source from plant material.
Colorado Springs, CO
Nonprofit research and education organization that has enrolled over 50,000 participants in its longitudinal cannabis registry — one of the largest observational datasets on real-world cannabis use, outcomes, and safety in the United States.
Santa Rosa, CA
Provider of cannabis reference standards, proficiency testing, and laboratory supplies for research institutions. Emerald's certified reference materials are used by academic labs to ensure analytical accuracy in cannabinoid quantification studies.
Leamington, Ontario
European medical cannabis supplier operating under EU-GMP standards. Provides pharmaceutical-grade cannabis flower and extracts to clinical trial sites across Germany, the UK, and the Netherlands, enabling standardized dosing in European research.
Rionegro, Colombia
Colombian-based producer of naturally-derived, standardized cannabis oils for pharmaceutical and nutraceutical applications. PharmaCielo's consistent, high-purity extracts are used in Latin American clinical research programs.
San Diego, CA
Investment and advisory firm focused on cannabis clinical research infrastructure. Supports the development of IRB-approved observational studies and provides funding for investigator-initiated research at academic medical centers.
Oakland, CA
Cannabis extraction and manufacturing company with a dedicated science team publishing on extraction efficiency, solvent residuals, and cannabinoid stability. Their technical reports contribute to formulation science literature.
We welcome inquiries from cannabis research companies, academic labs, pharmaceutical firms, and nonprofit organizations that contribute to the evidence base.
